Argus
•
Oct 28, 2026
HIMS: Lowering target price to $29.00
Summary
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss.
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Analyst Report: Reddit, Inc.
Oct 29, 2026
•
RDDT
Analyst Report: SoFi Technologies Inc
Oct 29, 2026
•
SOFI
Analyst Report: Robinhood Markets Inc
Oct 29, 2026
•
HOOD
Market Digest: BIIB, CMCSA, CNC, IEX, NEM, RCL, RTX, WEN, V, GNRC, CLF, HOOD, SOFI
Oct 29, 2026
•
WEN, CMCSA, V, NEM, RTX, SOFI, CNC, GNRC, RCL, CLF, HOOD, IEX, BIIB
Analyst Report: Robinhood Markets, Inc.
Oct 28, 2026
•
HOOD
